Coronary Bifurcation Stenting (COBIS) Registry in South Korea

Conditions

Coronary Bifurcation Lesion

Keywords

Coronary bifurcation lesion, Drug-eluting stent

Brief summary

The COBIS registry is multi-center, real-world registry of drug-eluting stenting in coronary bifurcation lesions in South Korea. The aim of the study was to find out the current status of bifurcation drug-eluting stenting and determine the prognostic factors for long-term outcome in South Korea.

Song PS, Song YB, Yang JH, Hahn JY, Choi SH, Choi JH, Koo BK, Seung KB, Park SJ, Gwon HC.

2014-07-108 citations

10.1016/j.rec.2014.01.032

Trans-radial versus trans-femoral intervention for the treatment of coronary bifurcations: results from Coronary Bifurcation Stenting Registry.

Chung S, Her SH, Song PS, Song YB, Hahn JY, Choi JH, Lee SH, Jang Y, Yoon JH, Tahk SJ, Park SJ, Choi SH, Seung KB, Gwon HC.

2013-03-0411 citations

10.3346/jkms.2013.28.3.388

Final kissing ballooning and long-term clinical outcomes in coronary bifurcation lesions treated with 1-stent technique: results from the COBIS registry.

Gwon HC, Hahn JY, Koo BK, Song YB, Choi SH, Choi JH, Lee SH, Jeong MH, Kim HS, Seong IW, Yang JY, Rha SW, Jang Y, Yoon JH, Tahk SJ, Seung KB, Park SJ.

2011-09-2076 citations

10.1136/heartjnl-2011-300322

Sirolimus- versus paclitaxel-eluting stents for the treatment of coronary bifurcations results: from the COBIS (Coronary Bifurcation Stenting) Registry.

Song YB, Hahn JY, Choi SH, Choi JH, Lee SH, Jeong MH, Kim HS, Seong IW, Yang JY, Rha SW, Jang Y, Yoon JH, Tahk SJ, Seung KB, Park SJ, Gwon HC.

2010-04-0143 citations

10.1016/j.jacc.2010.02.008

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

No

Inclusion criteria

* Age \>= 18 years * Any type of de novo bifurcation lesion with a parent vessel \>= 2.5 mm and side branch\>= 2.0 mm by visual estimation * Treated with drug-eluting stent

Exclusion criteria

* Cardiogenic Shock * ST elevation MI within 48hours * Expected survival less than 1 year * Left main bifurcation * Allergy to the antiplatelets

Design outcomes

Primary

Measure	Time frame
Incidence of the composite outcome of all-cause death, MI, or any PCI/CABG	3 years

Secondary

Measure	Time frame
Incidence of stent thrombosis, and periprocedural MI	3 years

Countries

South Korea

Outcome results